Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial (Q44067956)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial |
scientific article |
Statements
1 reference
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial (English)
1 reference
Scott M Grundy
1 reference
Gloria Lena Vega
1 reference
Mark E McGovern
1 reference
Brian R Tulloch
1 reference
David M Kendall
1 reference
David Fitz-Patrick
1 reference
Om P Ganda
1 reference
Robert S Rosenson
1 reference
David D Robertson
1 reference
John P Sheehan
1 reference
Diabetes Multicenter Research Group
1 reference
1 July 2002
1 reference
1 reference
Identifiers
1 reference